SEC Form 4 research
| Issuer | Acasti Pharma Inc. |
|---|---|
| Tickers | ACST, GRCE |
| Reporting owners | 24 |
| Officers and directors | 3 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-12 | Opaleye Management Inc. | P | 7,215 | $2.02 | Not reported |
| 2026-10-13 | 2026-10-09 | Opaleye Management Inc. | P | 5,340 | $2.04 | Not reported |
| 2026-10-13 | 2026-10-08 | Opaleye Management Inc. | P | 2,077 | $2.02 | Not reported |
| 2026-10-05 | 2026-10-05 | Opaleye Management Inc. | P | 1,694 | $2.06 | Not reported |
| 2026-10-05 | 2026-10-02 | Opaleye Management Inc. | P | 20,000 | $2.07 | Not reported |
| 2026-10-05 | 2026-10-01 | Opaleye Management Inc. | P | 38,796 | $2.04 | Not reported |
| 2026-10-01 | 2026-09-29 | Opaleye Management Inc. | P | 7,849 | $2.09 | Not reported |
| 2026-10-01 | 2026-09-23 | Opaleye Management Inc. | P | 5,318 | $2.1 | Not reported |
| 2026-10-01 | 2026-09-21 | Opaleye Management Inc. | P | 9,771 | $2.1 | Not reported |
| 2026-09-23 | 2026-09-23 | Opaleye Management Inc. | P | 5,318 | $2.1 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.